Eliquis Offered to Cash-Paying Patients at More Than 40% Discount to Current List Price, Sotyktu at More Than 80% Discount to Current List Price "We are proud to now offer Sotyktu at a lower price via ...

Bristol Myers Squibb announced an expansion of its direct-to-patient offerings, providing eligible US patients with steeply discounted prices for Eliquis (apixaban) and Sotyktu (deucravacitinib).

If you have been keeping an eye on Bristol-Myers Squibb (BMY), you may have noticed recent buzz surrounding its newest move: an expansion of its direct-to-patient Patient Connect platform. The company ...

Eliquis Offered to Cash-Paying Patients at More Than 40% Discount to Current List Price, Sotyktu at More Than 80% Discount to Current List Price PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb ...

Eliquis Offered to Cash-Paying Patients at More Than 40% Discount to Current List Price, Sotyktu at More Than 80% Discount to Current List Price Bristol Myers Squibb (NYSE: BMY) today announced an ...

Pickering Interfaces has added two PXI and two PXIe battery simulators to its line of PXI test modules. The 41-754 (PXI) and ...

Bristol Myers Squibb is following in the footsteps of some of its big pharma company peers that have rolled out direct-to-patient online platforms offering branded drugs at steep discounts. When BMS ...

Bristol Myers Squibb (NYSE: BMY) today announced an expansion of its direct-to-patient offerings, providing eligible U.S. patients with steeply discounted prices for Eliquis ® (apixaban) and Sotyktu ® ...